EssilorLuxottica Société anonyme

BIT:1EL Stock Report

Market Cap: €97.4b

EssilorLuxottica Société anonyme Valuation

Is 1EL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1EL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1EL (€213.7) is trading below our estimate of fair value (€250.76)

Significantly Below Fair Value: 1EL is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1EL?

Other financial metrics that can be useful for relative valuation.

1EL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.2x
Enterprise Value/EBITDA19.7x
PEG Ratio3x

Price to Earnings Ratio vs Peers

How does 1EL's PE Ratio compare to its peers?

The above table shows the PE ratio for 1EL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.3x
DIA DiaSorin
33x14.4%€5.5b
7741 HOYA
38.6x11.4%JP¥7.3t
ALC Alcon
43.4x11.4%CHF 41.0b
AMP Amplifon
38.2x18.5%€6.2b
1EL EssilorLuxottica Société anonyme
42.5x14.0%€97.4b

Price-To-Earnings vs Peers: 1EL is expensive based on its Price-To-Earnings Ratio (42.5x) compared to the peer average (38.3x).


Price to Earnings Ratio vs Industry

How does 1EL's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.9%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.9%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 1EL is expensive based on its Price-To-Earnings Ratio (42.5x) compared to the European Medical Equipment industry average (29.3x).


Price to Earnings Ratio vs Fair Ratio

What is 1EL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1EL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio42.5x
Fair PE Ratio34.2x

Price-To-Earnings vs Fair Ratio: 1EL is expensive based on its Price-To-Earnings Ratio (42.5x) compared to the estimated Fair Price-To-Earnings Ratio (34.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1EL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€213.70
€212.95
-0.4%
9.3%€250.00€173.00n/a19
Oct ’25€210.80
€212.95
+1.0%
9.3%€250.00€173.00n/a19
Sep ’25€206.10
€210.55
+2.2%
7.9%€235.00€173.00n/a20
Aug ’25€211.10
€210.05
-0.5%
8.0%€235.00€173.00n/a20
Jul ’25€202.30
€209.90
+3.8%
8.8%€235.00€162.00n/a20
Jun ’25€204.90
€206.95
+1.0%
8.2%€229.00€162.00n/a19
May ’25€200.80
€205.89
+2.5%
8.2%€229.00€162.00n/a19
Apr ’25€209.70
€201.16
-4.1%
7.6%€228.00€162.00n/a19
Mar ’25€197.74
€197.84
+0.05%
7.4%€220.00€162.00n/a20
Feb ’25€182.68
€192.54
+5.4%
7.5%€215.00€162.00n/a22
Jan ’25€181.28
€193.26
+6.6%
8.0%€220.00€162.00n/a22
Dec ’24€178.50
€193.04
+8.1%
8.2%€220.00€162.00n/a22
Nov ’24€171.26
€192.76
+12.6%
8.2%€220.00€162.00n/a22
Oct ’24€165.52
€194.59
+17.6%
8.5%€220.00€155.00€210.8021
Sep ’24€174.16
€194.15
+11.5%
8.7%€220.00€155.00€206.1020
Aug ’24€179.16
€194.50
+8.6%
8.7%€220.00€155.00€211.1020
Jul ’24€172.54
€192.63
+11.6%
8.4%€220.00€155.00€202.3019
Jun ’24€166.38
€191.94
+15.4%
8.2%€215.00€155.00€204.9018
May ’24€178.14
€191.46
+7.5%
7.8%€215.00€155.00€200.8020
Apr ’24€166.50
€186.01
+11.7%
8.0%€210.00€155.00€209.7019
Mar ’24€163.40
€187.69
+14.9%
8.4%€210.00€155.00€197.7419
Feb ’24€168.15
€187.06
+11.2%
8.7%€210.00€155.00€182.6819
Jan ’24€169.00
€184.66
+9.3%
9.5%€210.00€150.00€181.2820
Dec ’23€177.00
€179.98
+1.7%
9.0%€205.00€150.00€178.5019
Nov ’23€162.50
€179.98
+10.8%
9.0%€205.00€150.00€171.2619
Oct ’23€140.80
€179.71
+27.6%
9.5%€205.00€144.00€165.5218

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies